Nasal Atomization Devices Market Competitive LandscapeAccording to FutureWise analysis the market for Mucosal Atomization Devices in 2026 is US$ 0.62 billion, and is expected to reach US$ 1.25 billion by 2036 at a CAGR of 7.26%. Mucosal atomization devices are specialized drug delivery systems that admi...Feb 12, 2026·4 min read
MRI Compatible IV Infusion Pumps Industry Insights 2026–2036According to FutureWise analysis the market for mri compatible iv infusion pumps in 2026 is US$ 0.34 billion, and is expected to reach US$ 0.71 billion by 2036 at a CAGR of 7.64%. MRI-compatible IV infusion pumps are designed for safe use in MRI envi...Feb 12, 2026·3 min read
MRI Coils Market Growth Drivers and Competitive LandscapeAccording to FutureWise analysis the market for MRI coils in 2026 is US$ 2.95 billion, and is expected to reach US$ 7.24 billion by 2036 at a CAGR of 9.39%. MRI coils are vital for magnetic resonance imaging, functioning as antennas that transmit and...Feb 12, 2026·4 min read
Motion Stimulation Therapy Market Regional Analysis & Future OutlookAccording to FutureWise analysis the market for motion stimulation therapy in 2026 is US$ 1.35 billion, and is expected to reach US$ 2.14 billion by 2036 at a CAGR of 4.71%. The market is growing due to rising demand for non-invasive rehabilitation i...Feb 11, 2026·3 min read
Motion Sickness Treatment Market Regional Analysis & Future OutlookAccording to FutureWise analysis the market for Motion Sickness Treatment in 2026 is US$ 0.88 billion, and is expected to reach US$ 1.27 billion by 2036 at a CAGR of 3.74%. Market growth is driven by increasing global travel, cruise tourism, and the ...Feb 11, 2026·5 min read
Monoclonal Antibody Therapy Market Revenue Forecast to 2036According to FutureWise analysis the market for monoclonal antibody therapy in 2026 is US$ 359.42 billion, and is expected to reach US$ 1028.77 billion by 2036 at a CAGR of 11.09%. The growth in monoclonal antibodies is attributed to their expanding ...Feb 11, 2026·4 min read
Moyamoya Disease Market: Surgical & Drug Therapy SegmentsAccording to FutureWise analysis the market for moyamoya disease in 2026 is US$ 1.63 billion, and is expected to reach US$ 3.10 billion by 2036 at a CAGR of 6.64%. Market growth is driven by increasing awareness, improved diagnostic capabilities like...Feb 11, 2026·4 min read
